anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 21,091-21,120
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

21,091-21,120 of 26,550

filter-aware
04
The slide uses a conceptual graph showing the relationship between concentration, PPI, and viscosity, alongside a molecular diagram showing protein aggregation.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Problem Statement1 hit
05
The slide illustrates the mechanism of action for the SQore platform, showing the transition from high-viscosity, high-PPI protein clusters to low-viscosity, low-PPI clusters using excipients.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Proposed Solution1 hit
09
The slide uses visual comparisons of protein structures and corresponding RMSD and Hydrogen Bond plots to demonstrate the utility of MD simulations.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Methodology1 hit
10
The slide illustrates a dual-track approach (biophysical studies vs. computational modeling) feeding into an excipient selection matrix.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Methodology1 hit
11
Shows CD thermal melt data for Nivolumab, Trastuzumab, Pembrolizumab, and Ustekinumab.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Key Takeaways1 hit
109
The slide uses a before-after framework to illustrate the mechanism of action (MoA) of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
110
The slide uses two distinct chart types (bar chart with error bars and dot plot with mean/SEM bars) to demonstrate efficacy across two metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
111
Clinical: FAP context. Slide 111.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
112
The slide outlines a two-part clinical trial design (Part 1 and Part 2) with specific enrollment criteria and outcome measures.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
113
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
114
Includes a testimonial/quote from a KOL regarding the lack of therapeutic relevance in HCC.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
115
The slide uses a table to quantify the addressable market and a callout box to link preclinical data to the study design.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
116
The slide uses a heatmap to demonstrate biological similarity between drug dosage effects and specific gene regulation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
117
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
118
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
119
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
120
The slide uses a three-step process diagram to illustrate the biological mechanism of C. diff infection.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
01
Slide 1
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
02
Includes a timeline of regulatory/market events and a bar chart of historical revenue.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
03
Uses a contrast-pairs framework to highlight the divergence in business performance across regions.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
04
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
05
This slide serves as a track record or 'proof of competence' for the activist investor.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
06
Includes specific voting instructions and a call to action for a proxy contest.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
07
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
08
Includes NEJM citation and NNT (Number Needed to Treat) calculation.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
09
The slide uses a line chart to show mortality trends and a bar chart to show commercial success of blockbuster drugs.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
10
Uses a visual metaphor of a meat grinder to represent value destruction.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
11
The slide uses a large red arrow to emphasize the negative financial performance.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a visual gap analysis to emphasize the divergence between the company's stock and the broader sector index.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide uses a red arrow callout to emphasize the negative performance.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit